Authors:
LUM RT
NELSON MG
JOLY A
HORSMA AG
LEE G
MEYER SM
WICK MM
SCHOW SR
Citation: Rt. Lum et al., SELECTIVE-INHIBITION OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE 20S PROTEASOME BY 5-METHOXY-1-INDANONE DIPEPTIDE BENZAMIDES, Bioorganic & medicinal chemistry letters, 8(3), 1998, pp. 209-214
Authors:
LUM RT
KERWAR SS
MEYER SM
NELSON MG
SCHOW SR
SHIFFMAN D
WICK MM
JOLY A
Citation: Rt. Lum et al., A NEW STRUCTURAL CLASS OF PROTEASOME INHIBITORS THAT PREVENT NF-KAPPA-B ACTIVATION, Biochemical pharmacology, 55(9), 1998, pp. 1391-1397
Authors:
SCHOW SR
MACKMAN RL
BLUM CL
BROOKS E
HORSMA AG
JOLY A
KERWAR SS
LEE G
SHIFFMAN D
NELSON MG
WANG XB
WICK MM
ZHANG XM
LUM RT
Citation: Sr. Schow et al., SYNTHESIS AND ACTIVITY OF 2,6,9-TRISUBSTITUTED PURINES, Bioorganic & medicinal chemistry letters, 7(21), 1997, pp. 2697-2702
Authors:
MEYER S
LUM RT
NELSON MG
SCHOW SR
SHIFFMAN D
KERWAR SS
WICK MM
JOLY A
Citation: S. Meyer et al., INHIBITION OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE PROTEASOME PREVENTS LIPOPOLYSACCHARIDE-INDUCED NF-KAPPA-B ACTIVATION, The FASEB journal, 11(9), 1997, pp. 2180-2180
Authors:
BROOKS EE
GRAY NS
JOLY A
KERWAR SS
LUM R
MACKMAN RL
NORMAN TC
ROSETE J
ROWE M
SCHOW SR
SCHULTZ PG
WANG XB
WICK MM
SHIFFMAN D
Citation: Ee. Brooks et al., CVT-313, A SPECIFIC AND POTENT INHIBITOR OF CDK2 THAT PREVENTS NEOINTIMAL PROLIFERATION, The Journal of biological chemistry, 272(46), 1997, pp. 29207-29211
Citation: Dh. Zhang et al., HIV TYPE-1 PROTEASE ACTIVATION OF NF-KAPPA-B WITHIN T-LYMPHOID CELLS, AIDS research and human retroviruses, 11(2), 1995, pp. 223-230
Authors:
MUNGER W
DEJOY SQ
JEYASEELAN R
TORLEY LW
GRABSTEIN KH
EISENMANN J
PAXTON R
COX T
WICK MM
KERWAR SS
Citation: W. Munger et al., STUDIES EVALUATING THE ANTITUMOR-ACTIVITY AND TOXICITY OF INTERLEUKIN-15, A NEW T-CELL GROWTH-FACTOR - COMPARISON WITH INTERLEUKIN-2, Cellular immunology, 165(2), 1995, pp. 289-293
Authors:
DEJOY SQ
JEYASEELAN R
TORLEY LW
SCHOW SR
WICK MM
KERWAR SS
Citation: Sq. Dejoy et al., ATTENUATION OF INTERLEUKIN 2-INDUCED PULMONARY VASCULAR LEAK SYNDROMEBY LOW-DOSES OF ORAL METHOTREXATE, Cancer research, 55(21), 1995, pp. 4929-4935
Authors:
DEJOY SQ
JEYASEELAN R
TORLEY LW
PICKETT WC
WISSNER A
WICK MM
ORONSKY AL
KERWAR SS
Citation: Sq. Dejoy et al., EFFECT OF CL 184,005, A PLATELET-ACTIVATING-FACTOR ANTAGONIST IN A MURINE MODEL OF STAPHYLOCOCCUS-AUREUS INDUCED GRAM-POSITIVE SEPSIS, The Journal of infectious diseases, 169(1), 1994, pp. 150-156
Authors:
TROVA MP
BABINE RE
BYRN RA
CASSCLES WT
HASTINGS RC
HSU GC
JIROUSEK MR
JOHNSON BD
KERWAR SS
SCHOW SR
WISSNER A
ZHANG N
WICK MM
Citation: Mp. Trova et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF A SERIES OF HIV-1 PROTEASE INHIBITORS, Bioorganic & medicinal chemistry letters, 3(8), 1993, pp. 1595-1600
Authors:
JIROUSEK MR
CHEUNG AWH
BABINE RE
SASS PM
SCHOW SR
WICK MM
Citation: Mr. Jirousek et al., A SYNTHESIS OF INDOLIZIDINES RELATED TO CASTANOSPERMINE AND SWAINSONINE, Tetrahedron letters, 34(23), 1993, pp. 3671-3674